Three plaintiffs in the sprawling multidistrict litigation over the carcinogens found in the popular heartburn medication Zantac asked the Eleventh Circuit on Tuesday to revive their state law claims against generic and brand-name drugmakers but may face procedural roadblocks in their appeals. Over the course of three oral arguments before an appellate panel in Miami,… Continue reading Zantac MDL Plaintiffs Try To Revive Claims Against Drug Cos.